lystn

In this episode, Dr. Neil Skolnik and Dr. Leana S. Wen discuss addressing unmet needs in the management of COVID-19. They will discuss the importance of layering mitigation and protection strategies for those who are most at risk, along with the role of long-acting monoclonal antibodies for COVID-19 pre-exposure prophylaxis with emphasis on patients who are immunocompromised and may not respond to vaccination, in light of evolving variants.

This episode is part three of a three part series that examines the use of tixagevimab and cilgavimab for pre-exposure prophylaxis of COVID-19. 

 Funds for this activity have been provided by AstraZeneca.

This activity does not offer CME/CE credit

Faculty:

Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Associate Director
Family Medicine Residency Program
Abington Jefferson Health
Philadelphia, PA

Leana S. Wen, MD, MSc
Professor, Health Policy and Management
Distinguished Fellow, Fitzhugh Mullan Institute for
Health Workforce Equity
George Washington University School of Public Health 
Washington, DC

Please visit http://naceonline.com to engage in more live and on demand CME/CE content.